Human brain receptor alterations in suicide victims

• Published in: Pharmacology, biochemistry and behavior Vol. 17; no. 1; pp. 159 - 163
• Main Authors: Meyerson, Laurence R., Wennogle, Lawrence P., Abel, Marc S., Coupet, Joseph, Lippa, Arnold S., Rauh, Charles E., Beer, Bernard
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.1982
• Subjects: Antidepressive Agents, Tricyclic - pharmacology; Brain - metabolism; Cerebral Cortex - metabolism; Cholinergic receptors; Depression; Dihydroalprenolol; Humans; Imipramine; In Vitro Techniques; Nerve Tissue Proteins - metabolism; Quinuclidinyl Benzilate; Receptors, Neurotransmitter - metabolism; Serotonin; Suicide; Imipramine; Depression; Serotonin; Cholinergic receptors; Suicide
• ISSN: 0091-3057; 1873-5177
• DOI: 10.1016/0091-3057(82)90279-9

A comparison was made of human postmortem muscarinic-cholinergic, β-adrenergic and serotonergic (presynaptic) recognition sites in cortical tissues derived from suicide and homicide (control) victims. An elevation of 47% and 35% in the suicide group compared to controls was observed in receptor ligand binding for 3H-quinuclidinyl benzilate (QNB, muscarinic antagonist) and 3H-imipramine (IMI, a presynaptic serotonin marker), respectively. In contrast, no appreciable differences in 3H-dihydroalprenolol (DHA, β-adrenergic antagonist) binding were observed between the two groups. Additionally, tissues from both groups of subjects were analyzed for tricyclic antidepressive agent (TAD) content. High performance liquid chromatographic (HPLC) tissue analysis revealed no detectable levels of tricyclic agents with an assay sensitivity of 50 picograms/mg tissue. The results presented herein demonstrate neurotransmitter-receptor alterations in suicide subjects compared to homicide (control) victims. The attendant roles of serotonergic and muscarinic-cholinergic processes in the psychobiology of suicide and depression are addressed.